
TSE:MFC
This summary was created by AI, based on 28 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.
If we see stock markets moving higher and interest rates moving moderately higher, that is a good catalyst for the share price. In addition, the fundamental business is going well, particularly in Asia. If you have a 3-5 year view, this could be a core holding to have. He would like to see it pull back a bit before buying.
Lifecos had a big run up in 2013. A lot of that was multiple driven. We are now experiencing some earnings growth, but there is a bit of a consolidation taking place as 2014 earnings have to catch up with the multiple. It probably will because we have a good environment and interest rates are moving up. He is lukewarm on this and is in the “show me” state. Wants to see those earnings because if he doesn’t, it has run ahead of its multiples.
They have taken a lot of leverage out of it. From a technical perspective, we see a descending triangle taking place (bearish). Just finished the end of the seasonal period and he sees declining interest rates which are not good. A break down below $19 would show weakness form a technical perspective.
Hit $22 in January, but is now hovering around $20, which is not an insignificant correction. Has to do with the market and the underlying returns with some of their portfolios. Their international business is still quite small. They are having a little bit of difficulty with perception, but this is one you want to pick up right here at this price.
The worst is over for this company. Earnings rebounded this year and he is looking at double digit earnings growth for 2015. To him, that means we are going to start seeing the dividend increasing again. They are suddenly doing everything right. Have a great global presence. Their whole hedging strategy, which caused them problems, has been well thought out and cleaned up. Dividend yield of 2.5%.
Increase in rates and in equity markets is good for insurance companies. It is cheaper than some of the others. Operating earnings came over quite decently this quarter. This also gives you exposure into Asia, a higher growth areas. Not cheap. You are probably going to have lower ROE then you have had in the past because they have pulled back on some of their riskier business. A good holding.